Trial Profile

A Phase 1 Randomized Double-Blind Placebo-controlled Single and Multiple Ascending Dose Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis or Atopic Dermatitis

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 11 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EDP-1815 (Primary)
Indications Atopic dermatitis; Psoriasis
Focus Adverse reactions; First in man
Sponsors Evelo Biosciences

Most Recent Events

08 Dec 2021 Status changed from recruiting to completed.
29 Apr 2021 According to an Evelo Biosciences media release, data from Phase 1b cohorts with tablets and capsules is anticipated to be reported in 3Q 2021.
20 Apr 2021 According to an Evelo Biosciences media release, results from this study presented at the International Society of Atopic Dermatitis Annual Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com